According to research, new drug approval in the United States take an average of 12 years from pre-clinical testing to approval1. So, when you consider how quickly the drug discovery industry rallied to understand the Covid-19 virus and roll out a vaccine, the value of collaboration becomes not just apparent but essential. We are in […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!